StockTipsArenaBeta

BUY Marksans Pharma Limited — IDBI Capital

BUYMarksans Pharma Limited
Marksans Pharma share price target & all analyst calls

byIDBI CapitalHorizon: NA (inferred 1–3 months)29 Sept 2026via IDBI Capital Research Calls Telegram

Entry₹345Stated
Target₹380
Total upside +10.14% (call closed)
Stop loss₹329-4.64% risk
Exit₹32930 Sept 2026, 12:09 pm
Stop-loss hit-4.64%
Follow IDBI Capital for new calls(33% target hit, 208 closed calls)Get alertsWatch MARKSANS for new buy/sell callsGet alertsSee 1 active Short-term call on MARKSANSSee 84 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 30 Sept 2026
2 supporting2 neutral0 opposing
Supports the BUY call (2)

2 advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·29 Sept · yesterday

1 other SEBI-registered advisor has an active short-term BUY call on this stock

Advisor consensus · same horizon·18 Aug · 1mo ago

Neutral / worth noting (2)

Marksans Pharma Opens SEBI-Mandated Window for Re-Lodging Physical Share Transfers

NewsGoogle News·17 Sept · 2w ago

(opens in new tab)

Marksans Pharma opens special window for re-lodgement of physical share transfer requests

NewsGoogle News·17 Sept · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Marksans Pharma

All analyst calls on Marksans Pharma

More from IDBI Capital

Every call and its outcome